Item 1. Legal Proceedings
ITEM 1. Legal Proceedings
We are subject to the legal proceedings and claims
discussed below as well as certain other legal proceedings and claims that have not been fully resolved and that have arisen in the ordinary
course of business. Our management evaluates our exposure to these claims and proceedings individually and in the aggregate and evaluates
potential losses on such litigation if the amount of the loss is estimable and the loss is probable. However, the outcome of legal proceedings
and claims brought against the Company is subject to significant uncertainty. Although management considers the likelihood of such an
outcome to be remote, if one or more of these legal matters were resolved against the Company for amounts in excess of management’s
expectations, the Company’s financial statements for that reporting period could be materially adversely affected.
In 2017, the Company’s former COO was awarded
approximately $238 in accrued salary and related charges by the California labor board. In August 2021, the Company reached a settlement
by which the Company agreed to pay approximately $330, representing the principal award plus accrued interest. As of the time of this
filing, the Company has paid the full amount toward the settlement amount, leaving no remaining balance.
In March 2024, the Company and Kopple again amended
the note payable. The amendment (i) replaced the requirement to pay the $3,850 past due principal balance with the requirement to
pay $2,000 due December 15, 2024, effectively extending the payment of $1,850 to future periods; (ii) increased the stated
interest rate to 10%; (iii) added a fee of $15 monthly until the Company makes a principal payment of $2 million by December
2024; (iv) effective August 30, 2024, the Company will grant Kopple a conversion right that gives Kopple the option to be able to convert
the note payable into equity of the Company at a conversion price of the lower of $1.00 per share or 50% of the 10 day
volume weighted average price of the Company’s common stock; (v) during Fiscal 2025, will require the Company to pay 20% of
all collected revenues within 10 days of the end of each fiscal quarter; (vi) will require the Company to pay Kopple 20% of any amount
raised in new capital in the form of equity, debt or convertible debt above $3.5 million; (vii) reduces the exercise price of the
warrants granted to Kopple in March 2022 from $0.85 per share to $0.50 per share; and (vii) extends the warrant expiration date
from March 8, 2029, to March 31, 2031. The Company will account for this amendment in the first quarter ended March 31, 2024, for
fiscal year 2025.
On March 26, 2019, various stockholders of the
Company controlling a combined total of more than 27.5 million shares delivered a signed written consent to the Company removing Ronald
Buschur as a member of the Company’s Board and electing Cipora Lavut as a director of the Company. On March 27, 2019, those
same stockholders delivered a further signed written consent to the Company removing William Anderson and Si Ryong Yu as members of the
Company’s Board and electing Robert Lempert and David Mann as directors of the Company. These written consents represented a majority
of the outstanding shares of the Company’s common stock as of March 26, 2019, and March 27, 2019, respectively. Because
of Aura’s refusal to recognize the legal effectiveness of the consents, on April 8, 2019, the stockholders filed suit in the
Court of Chancery of the State of Delaware pursuant to Section 225 of the Delaware General Corporations Law, seeking an order confirming
the validity of the consents and declaring that Aura’s Board consists of Ms. Lavut, Mr. Mann, Dr. Lempert, Mr. Douglas
and Mr. Diaz-Versón, Jr. On July 8, 2019 the Court of Chancery entered final judgment in favor of the stockholder plaintiffs,
confirming that (a) Ronald Buschur, Si Ryong Yu and William Anderson had been validly removed by the holders of a majority of the Company’s
outstanding stock acting by written consent (b) Ms. Lavut, Mr. Mann and Dr. Lempert had been validly elected by the holders of a majority
of the Company’s outstanding stock acting by written consent, and (c) the Company’s Board of Directors validly consists of
Cipora Lavut, David Mann, Robert Lempert, Gary Douglas and Salvador Diaz-Versón, Jr. As a result of prior management’s unsuccessful
opposition to this stockholders’ action filed in the Court of Chancery, such stockholders may be potentially entitled to recoup
their litigation costs from the Company under Delaware’s corporate benefit doctrine and/or other legal provisions. To date, no final
determination has been made as to the amount of recoupment, if any, to which such stockholders may be entitled.
23
In June 2022, Melvin Gagerman, the Company’s
former CEO and CFO whose employment with Aura was permanently terminated in July 2019, brought suit against the Company for repayment
of an allegedly unsecured demand promissory note in the principal amount of $82 which he claims was entered into in April 2014 and bears
interest at a rate of 10% per annum. Despite the fact that, based on Gagerman’s allegations, the note was issued during a period
when he was the Company’s CEO, CFO, Corporate Secretary and Chairman of Aura’s Board of Directors, Gagerman has stated that
he does not possess a copy of the alleged promissory note. The Company disputes that any amount is presently owed to Gagerman and has
filed a cross-complaint against him for, among things, conversion, violation of California Business& Professions Code §17200,
and various breaches of fiduciary duty that the Company believes Gagerman committed against Aura, including without limitation, Gagerman’s
actions in opposing the valid 2019 stockholder consent action.
ITEM 1A. Risk Factors
In addition to the other information set forth
in this report, you should carefully consider the risk factors disclosed in Item 1A, “Risk Factors,” of the Company’s
Fiscal 2024 Annual Report on Form 10-K issued on June 4, 2024.
ITEM 2. Unregistered Sales of Equity Securities
and Use of Proceeds
During the six-months ended August 31, 2024, the
Company issued 7,875,600 shares of common stock for approximately $1,763 in net cash.
ITEM 3. Defaults Upon Senior Securities.
None
ITEM 4. Mine Safety Disclosures
Not applicable.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.